Cost-effectiveness analysis of different combination therapies for the treatment of chronic lymphocytic leukaemia in IndiaResearch in context

Cost-effectiveness analysis of different combination therapies for the treatment of chronic lymphocytic leukaemia in IndiaResearch in context

Summary: Background: Over the years, there has been introduction of newer drugs, like bendamustine and ibrutinib, for the management of chronic lymphocytic leukaemia (CLL). Though these drugs lead to better survival, they are also associated with higher cost. The existing evidence on cost effective...

Full description

Bibliographic Details
Main Authors: Prerika Nehra, Akashdeep Singh Chauhan, Pankaj Malhotra, Lalit Kumar, Ashish Singh, Nidhi Gupta, Nikita Mehra, Anisha Mathew, Amal Chandra Kataki, Sudeep Gupta, Shankar Prinja
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:The Lancet Regional Health - Southeast Asia
Subjects:
Cost effectiveness
Leukaemia
Chemotherapy
Economic evaluation
Online Access:http://www.sciencedirect.com/science/article/pii/S2772368223000616

Internet

http://www.sciencedirect.com/science/article/pii/S2772368223000616

Similar Items